A Therapeutic Workplace for Drug Abusers

The purpose of this study is to determine whether long-term exposure to the Therapeuitc Workplace intervention could sustain drug abstinence over an extended period of time in heroin- and cocaine-dependent, unemployed, treatment-resistant young mothers.

Description

The current study is a continuation of the research into the development and evaluation of a novel treatment designed to address the chronic, persistent nature of drug addiction. This treatment, called the Therapeutic Workplace, integrates abstinence reinforcement contingencies of proven efficacy into a model supported work program. Participants were paid to work or to train in the Therapeutic Workplace but had to provide drug-free urine samples to gain daily access. Forty participants were randomly assigned to a Therapeutic Workplace or usual care control group. Therapeutic Workplace participants could work for about 5 years. This study reports the effects of the intervention over a follow-up period of 8 years after treatment initiation.

Status: Active, not recruiting (N/A). Started on October 1st, 1996. Ended on January 1st, 2006.

Enrollment: 40 subjects

Study Type: Interventional

Study Design:

Treatment
Randomized
Open Label
Parallel Assignment
Efficacy Study

Conditions:

Interventions:

Behavioral: Contingency management

Eligibility

Inclusion Criteria:

When originally enrolled in the study, participants were at least 18 years old, unemployed, and methadone maintenance patients of the Center for Addiction and Pregnancy (CAP) who continued to use opiates or cocaine during CAP treatment.

Exclusion Criteria:

Participants were excluded if they were at risk for suicide at the time of intake or if they had serious psychiatric illness (e.g., schizophrenia).

Gender: Female
Mininum Age: 18 Years
Maximum Age: 50 Years
Healthy Volunteers: No

Resources

Source: National Institute on Drug Abuse (NIDA)

Authority: United States: Federal Government

Locations

The Center for Learning and Health
Baltimore
Maryland
21224
United States

Officials

Kenneth Silverman, Ph.D. (Principal Investigator, Johns Hopkins University)

References

None.

Links

None.

Date Verified: November 1st, 2005
First Received: November 3rd, 2005
Last Changed: November 3rd, 2005

Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.

All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.

The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.

Healia Clinical Trials Information Database